BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30090635)

  • 1. Guillain-Barré syndrome hyponatremia: is it SIADH or pseudohyponatremia?
    Zemke AM; Boles LH; Gillespie M; Viljoen JM
    Oxf Med Case Reports; 2018 Jul; 2018(7):omy042. PubMed ID: 30090635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium Levels Predict Disability at Discharge in Guillain-Barré Syndrome: A Retrospective Cohort Study.
    Gagliardi D; Faravelli I; Podestà MA; Brusa R; Mauri E; Saccomanno D; Di Fonzo A; Bonato S; Scarpini E; Bresolin N; Comi GP; Corti S
    Front Neurol; 2021; 12():729252. PubMed ID: 34557155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyponatraemic encephalopathy as the initial presentation of Guillain-Barre syndrome.
    Ramanathan M
    Med J Malaysia; 2008 Dec; 63(5):426-7. PubMed ID: 19803310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syndrome of inappropriate anti-diuretic hormone in Kawasaki disease.
    Mori J; Miura M; Shiro H; Fujioka K; Kohri T; Hasegawa T
    Pediatr Int; 2011 Jun; 53(3):354-7. PubMed ID: 21029251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of autonomic dysfunction in hospitalized patients with Guillain-Barré syndrome.
    Anandan C; Khuder SA; Koffman BM
    Muscle Nerve; 2017 Aug; 56(2):331-333. PubMed ID: 28039863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial.
    Walgaard C; Jacobs BC; Lingsma HF; Steyerberg EW; Cornblath DR; van Doorn PA;
    J Peripher Nerv Syst; 2018 Dec; 23(4):210-215. PubMed ID: 30151941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A patient with Fisher syndrome and pharyngeal-cervical-brachial variant of Guillain-Barré syndrome having a complication of SIADH].
    Murakami T; Yoshihara A; Kikuchi S; Yasuda M; Hoshi A; Ugawa Y
    Rinsho Shinkeigaku; 2013; 53(4):299-303. PubMed ID: 23603545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albumin levels as a biomarker for second Intravenous Immunoglobulin (IVIG) treatment in Guillain-Barre syndrome (GBS).
    Shalman A; Savir S; Mechnik Steen Y; Ovanyan A; Boniel N; Koyfman L; Bichovsky Y; Zlotnik A; Klein M; Brotfain E
    J Clin Neurosci; 2020 Apr; 74():247-249. PubMed ID: 32088107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of Guillain-Barré syndrome accompanied by syndrome of inappropriate secretion of antidiuretic hormone].
    Inoue M; Kojima Y; Shirakashi Y; Kanda M; Shibasaki H
    Rinsho Shinkeigaku; 2010 Oct; 50(10):710-3. PubMed ID: 21061550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS).
    van Doorn PA
    Presse Med; 2013 Jun; 42(6 Pt 2):e193-201. PubMed ID: 23628447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Admission sodium level and prognosis in adult Guillain-Barré syndrome.
    Sipilä JO; Kauko T; Soilu-Hänninen M
    Int J Neurosci; 2017 Apr; 127(4):344-349. PubMed ID: 26971365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syndrome of Inappropriate Secretion of Antidiuretic Hormone Preceding Guillain-Barré Syndrome.
    James J; Jose J
    J Clin Diagn Res; 2017 Sep; 11(9):OD16-OD17. PubMed ID: 29207765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guillain-Barré syndrome and hyponatraemia.
    Colls BM
    Intern Med J; 2003; 33(1-2):5-9. PubMed ID: 12534871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins.
    Fokkink WJ; Selman MH; Dortland JR; Durmuş B; Kuitwaard K; Huizinga R; van Rijs W; Tio-Gillen AP; van Doorn PA; Deelder AM; Wuhrer M; Jacobs BC
    J Proteome Res; 2014 Mar; 13(3):1722-30. PubMed ID: 24533874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyponatremia in Guillain-Barré Syndrome.
    Rumalla K; Reddy AY; Letchuman V; Mittal MK
    J Clin Neuromuscul Dis; 2017 Jun; 18(4):207-217. PubMed ID: 28538251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barré syndrome.
    Buchwald B; Ahangari R; Weishaupt A; Toyka KV
    Ann Neurol; 2002 Jun; 51(6):673-80. PubMed ID: 12112071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IVIg-induced plasmablasts in patients with Guillain-Barré syndrome.
    Brem MD; Jacobs BC; van Rijs W; Fokkink WJR; Tio-Gillen AP; Walgaard C; van Doorn PA; IJspeert H; van der Burg M; Huizinga R
    Ann Clin Transl Neurol; 2019 Jan; 6(1):129-143. PubMed ID: 30656191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Guillain-Barrè syndrome and inadequate antidiuretic hormone secretion syndrome].
    Pöschl P; Kohl Z; Thoden U; Winkler J; Jakob W
    Nervenarzt; 2006 Dec; 77(12):1469-72. PubMed ID: 17131102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flaccid Paralysis with Hyponatremia: Think Guillain-Barre Syndrome.
    Griffin D; Asad H; Patel P; Gohar A
    Cureus; 2020 Feb; 12(2):e7113. PubMed ID: 32257660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barré Syndrome and Posterior Reversible Encephalopathy Syndrome following Spinal Surgery.
    Sanpei Y; Hanazono A; Kamada S; Sugawara M
    Case Rep Neurol; 2019; 11(3):284-289. PubMed ID: 31607895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.